NCT06595615

Brief Summary

Utilization of additional wearable data to improve clinical outcome

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for all trials

Timeline
17mo left

Started Mar 2025

Typical duration for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress52%
Mar 2025Dec 2027

First Submitted

Initial submission to the registry

August 27, 2024

Completed
23 days until next milestone

First Posted

Study publicly available on registry

September 19, 2024

Completed
5 months until next milestone

Study Start

First participant enrolled

March 1, 2025

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2027

Expected
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2027

Last Updated

January 14, 2025

Status Verified

January 1, 2025

Enrollment Period

1.8 years

First QC Date

August 27, 2024

Last Update Submit

January 13, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Acquisition of additional health data using patient App

    Health data acquisition via an app from multiple wearables and externals.

    12 months

Interventions

Standard of care patients indicated for the devices

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients indicated for cardiac implantable medical devices

You may qualify if:

  • Patients are willing to be compliant with daily measurements required 18 years of age or older
  • Patients who have been implanted with ABT CRT-D devices connected to Merlin.net
  • Patients who had at least one HF clinical event during past 12 calendar months
  • Must provide written informed consent prior to the commencement of this clinical feasibility study
  • Patients are willing to be compliant with daily measurements required

You may not qualify if:

  • Pregnant and/or lactating mothers will be excluded from the study or have a plan to be pregnant in the next 12 months
  • Patients with a life expectancy less than the duration of the study, as per clinician's discretion.
  • Patients who will not be able to complete the daily survey questions due to inability to read

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Heart Diseases

Condition Hierarchy (Ancestors)

Cardiovascular Diseases

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 27, 2024

First Posted

September 19, 2024

Study Start

March 1, 2025

Primary Completion (Estimated)

January 1, 2027

Study Completion (Estimated)

December 1, 2027

Last Updated

January 14, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share